1. BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling‐dependent tumor growth in mouse models. Issue 2 (20th October 2016) Authors: Politz, Oliver; Siegel, Franziska; Bärfacker, Lars; Bömer, Ulf; Hägebarth, Andrea; Scott, William J.; Michels, Martin; Ince, Stuart; Neuhaus, Roland; Meyer, Kirstin; Fernández‐Montalván, Amaury Ernesto; Liu, Ningshu; von Nussbaum, Franz; Mumberg, Dominik; Ziegelbauer, Karl Journal: International journal of cancer Issue: Volume 140:Issue 2(2017:Jan. 15) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗